Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Bayer AG."
8 result(s) displayed (1 - 8 of 8)
The transaction is a rare piece of M&A for the German pharmaceutical company, which lost out in the bidding for Schiff Nutrition last year. Continue reading
Posted on April 30, 2013 9:00 AM
Often mentioned as a takeover candidate, the CEO of the company with a vibrant oncology drug pipeline tells those gathered at the BIO CEO & Investor Conference that it may become an acquirer. Continue reading
Posted on February 12, 2013 3:43 PM
The U.K. group offers $1.4 billion for the Salt Lake City company as it seeks to establish a vitamin and nutrition business. Continue reading
Posted on November 16, 2012 9:14 AM
The two German companies will collaborate on the development of three compounds for the female health malady over a five-year period under a deal that could be worth as much as $750 million. Continue reading
Posted on October 1, 2012 4:04 PM
The German company will pay an initial $425 million for the California-based biological pest control specialist. Continue reading
Posted on July 5, 2012 12:26 PM
Discussions with potential bidders are at a preliminary stage, says the Irish drugmaker, which is 30.6% owned by THL, Bain Capital and CCMP Capital Advisors Continue reading
Posted on April 30, 2012 3:15 PM
Nestlé triumphs over Danone with a bid valuing the business at 19.8 times forecast Ebitda Continue reading
Posted on April 23, 2012 10:28 AM
Pfizer Inc. and Bristol-Myers Squibb Co. have released the full results of the study for their oral anti-coagulant drug, Eliquis, and the figures have reaffirmed analysts' predictions that the treatment will be the leading candidate in the race to replace... Continue reading
Posted on August 29, 2011 1:10 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
